Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein

腺病毒 E4-ORF3 蛋白对核信号通路的调节

基本信息

  • 批准号:
    8866365
  • 负责人:
  • 金额:
    $ 32.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Viruses with linear, dsDNA genomes, such as the adenoviruses (Ad) and herpesviruses, encounter a number of host cell responses that may severely inhibit virus replication. This proposal focuses on the adenovirus E4-ORF3 protein which promotes virus replication by counteracting cellular antiviral responses. Adenoviruses have been recognized in recent years as significant pathogens in immunocompromised patients. There is no virus-specific therapy for Ad infection. It has become increasingly important, therefore, to fully understand host responses to Ad infection and viral strategies used to inhibit these responses in order to foster the development of antiviral therapies. The Ad E4-ORF3 protein functions by relocalizing a variety of cellular proteins into nuclear structures, referred to as tracks, to inhibit their activities. E4-ORF3 inhibits a DNA damage response and counteracts an interferon (IFN) response during infection. The E4-ORF3 protein induces the sumoylation of two cellular proteins, Nbs1 and Mre11, which are critically important effectors in a cellular DNA damage response. E4-ORF3 also binds SUMO and uses SUMO binding motifs to relocalize cellular proteins into nuclear tracks. These results place E4-ORF3 at the nexus of the cellular sumoylation system. Post-translational protein modification by SUMO regulates diverse cellular processes including transcription, DNA replication, DNA repair, subcellular localization, and ubiquitination. The induction of cellular protein sumoylation by E4-ORF3 likely is used to inhibit host antiviral activities. Studies are proposed to investigate the mechanism by which E4-ORF3 induces Nbs1 and Mre11 sumoylation, the functional consequences of these modifications, and identify and investigate other cellular proteins whose sumoylation is induced by E4-ORF3. The interaction of the E4-ORF3 protein with SUMO may represent the foundation by which E4-ORF3 recruits sumoylated cellular proteins into nuclear tracks and experiments are proposed to test this idea. The E4-ORF3 protein inhibits an IFN response during Ad infection by sequestering the proteins PML and Daxx, two prominent antiviral effectors. The mechanism(s) by which PML and Daxx inhibit Ad replication during the IFN-induced antiviral state will be investigated. The contribution of two other targets of E4-ORF3, transcriptional repressors TIF1� and TIF1�, during an IFN response will be determined. The E4- ORF3 protein recruits a large number of different cellular proteins, associated with a variety of functions, into nuclear tracks. How this small viral protein accomplishes this is unknown. Physical analyses of wild type and mutant E4-ORF3 proteins will be conducted with the goal to study E4-ORF3 protein structure as it relates to function. Collectively, these studies will provide unique insight into cellular mechanisms that interfere with virus replication and viral responses that counteract these effects.
描述(由申请人提供):具有线性,dsDNA基因组的病毒,如腺病毒(Ad)和疱疹病毒,遇到许多可能严重抑制病毒复制的宿主细胞反应。本研究的重点是通过对抗细胞抗病毒反应促进病毒复制的腺病毒E4-ORF3蛋白。近年来,腺病毒已被认为是免疫功能低下患者的重要病原体。目前尚无针对Ad感染的病毒特异性治疗方法。因此,为了促进抗病毒治疗的发展,充分了解宿主对Ad感染的反应和用于抑制这些反应的病毒策略变得越来越重要。Ad E4-ORF3蛋白通过将多种细胞蛋白重新定位到核结构(称为轨道)中来抑制其活性。在感染期间,E4-ORF3抑制DNA损伤反应并抵消干扰素(IFN)反应。E4-ORF3蛋白诱导两种细胞蛋白Nbs1和Mre11的sumo化,这两种蛋白在细胞DNA损伤反应中是至关重要的效应物。E4-ORF3也结合SUMO并利用SUMO结合基序将细胞蛋白重新定位到核轨道上。这些结果表明E4-ORF3处于细胞酰化系统的联系中。SUMO通过翻译后蛋白修饰调节多种细胞过程,包括转录、DNA复制、DNA修复、亚细胞定位和泛素化。E4-ORF3诱导细胞蛋白sumo化可能用于抑制宿主抗病毒活性。我们将进一步研究E4-ORF3诱导Nbs1和Mre11 sumoylation的机制,以及这些修饰的功能后果,并鉴定和研究其他由E4-ORF3诱导sumoylation的细胞蛋白。E4-ORF3蛋白与SUMO的相互作用可能代表了E4-ORF3将sumylated细胞蛋白招募到核轨道的基础,并提出了实验来验证这一想法。在Ad感染期间,E4-ORF3蛋白通过隔离蛋白PML和Daxx抑制IFN反应,这两种蛋白是两种主要的抗病毒效应器。在ifn诱导的抗病毒状态下,PML和Daxx抑制Ad复制的机制将被研究。在IFN应答过程中,E4-ORF3的另外两个靶标——转录抑制因子TIF1′和TIF1′的作用将被确定。E4- ORF3蛋白将大量与多种功能相关的细胞蛋白招募到核轨道中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICK HEARING其他文献

PATRICK HEARING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICK HEARING', 18)}}的其他基金

A Novel Strategy for Recombinant Adeno-Associated Virus Vector Production
重组腺相关病毒载体生产的新策略
  • 批准号:
    8444147
  • 财政年份:
    2013
  • 资助金额:
    $ 32.53万
  • 项目类别:
A Novel Strategy for Recombinant Adeno-Associated Virus Vector Production
重组腺相关病毒载体生产的新策略
  • 批准号:
    8601421
  • 财政年份:
    2013
  • 资助金额:
    $ 32.53万
  • 项目类别:
Role of Adenovirus Core Proteins in Innate Signaling and Viral Genome Packaging
腺病毒核心蛋白在先天信号传导和病毒基因组包装中的作用
  • 批准号:
    8401416
  • 财政年份:
    2012
  • 资助金额:
    $ 32.53万
  • 项目类别:
Role of Adenovirus Core Proteins in Innate Signaling and Viral Genome Packaging
腺病毒核心蛋白在先天信号传导和病毒基因组包装中的作用
  • 批准号:
    8493994
  • 财政年份:
    2012
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
  • 批准号:
    10435502
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
  • 批准号:
    8540975
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4 ORF3 Protein
腺病毒 E4 ORF3 蛋白对核信号通路的调节
  • 批准号:
    7405395
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4 ORF3 Protein
腺病毒 E4 ORF3 蛋白对核信号通路的调节
  • 批准号:
    7579153
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
  • 批准号:
    8321122
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
  • 批准号:
    9099752
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 32.53万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 32.53万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 32.53万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 32.53万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了